Posted on November 20, 202011/20/20
Leadership Briefing – The U.S. Pharmaceutical Market Outlook: The Path to Recovery and the New Normal
Posted on November 6, 202011/6/20
The Power of Working Together With the Rare Disease Community
Posted on October 22, 202010/22/20
Three Keys To Value For Unlocking The Promise Of Cell Therapies
Posted on October 13, 202010/13/20
eBook – 2020 Stories That Shaped Commercialization
Posted on September 13, 20199/13/19
Driving the Commercialization of Regenerative Medicine
Posted on June 19, 20196/19/19
Gene Therapy for Rare Disorders
Posted on June 19, 20196/19/19
Could CMS Policies Impact Investments in CAR T-cell Therapies and Other Innovative Treatments?
Posted on June 15, 20196/15/19